{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:18:38Z","timestamp":1778206718386,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology of the Republic of China","award":["105-2325-B-037-003"],"award-info":[{"award-number":["105-2325-B-037-003"]}]},{"name":"Ministry of Science and Technology of the Republic of China","award":["103-2325-B-006-021-CC2"],"award-info":[{"award-number":["103-2325-B-006-021-CC2"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jmii.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T03:00:26Z","timestamp":1498705226000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment"],"prefix":"10.1016","volume":"51","author":[{"given":"Cheng-Yu","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-6783","authenticated-orcid":false,"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2017.05.008_bib1","first-page":"829","article-title":"Treatment of multidrug-resistant tuberculosis: evidence and controversies","volume":"10","author":"Caminero","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.200308-1159OC","article-title":"Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis","volume":"169","author":"Chan","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2017.05.008_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2017.05.008_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3201\/eid1411.080729","article-title":"Multidrug- and extensively drug-resistant tuberculosis","volume":"14","author":"Eker","year":"2008","journal-title":"Ger Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-8-10","article-title":"Multidrug-resistant tuberculosis","volume":"8","author":"Zager","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib6","series-title":"Guideline for the programmatic management of drug-resistant tuberculosis: 2011 update","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.jmii.2017.05.008_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmii.2015.12.008","article-title":"VDR and VDBP genes polymorphisms associated with susceptibility to tuberculosis in a Han Taiwanese population","volume":"49","author":"Lee","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.05.008_bib8","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jmii.2017.05.008_bib9","series-title":"Ministry of health and welfare. Taiwan. Annual report","author":"Center for Disease Control","year":"2015"},{"key":"10.1016\/j.jmii.2017.05.008_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165222","article-title":"Population-based drug resistance surveillance of multidrug-resistant tuberculosis in Taiwan, 2007\u20132014","volume":"11","author":"Chuang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2017.05.008_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","author":"Gunther","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jmii.2017.05.008_bib12","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB):2010 global report on surveillance and response. Update: April 11, 2014. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf."},{"key":"10.1016\/j.jmii.2017.05.008_bib13","series-title":"Golbal tuberculosis report","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jmii.2017.05.008_bib14","series-title":"Press release: WHO global task force outlines measures to combat XDR-TB worldwide","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.jmii.2017.05.008_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3201\/eid1405.071398","article-title":"Extensively drug-resistant tuberculosis, Taiwan","volume":"14","author":"Yu","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jmii.2017.05.008_bib17","series-title":"Taiwan tuberculosis, control report","author":"Centers for Disease Control, Ministry of Health and Welfare","year":"2014"},{"key":"10.1016\/j.jmii.2017.05.008_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0929-6646(11)60076-4","article-title":"Trends in tuberculosis in Taiwan, 2002\u20132008","volume":"110","author":"Lo","year":"2011","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.05.008_bib19","article-title":"Molecular epidemiology of tuberculosis in Kaohsiung City located at southern Taiwan, 2000-2008","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2017.05.008_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.2016.303152","article-title":"Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case-control study","volume":"106","author":"Pan","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jmii.2017.05.008_bib21","series-title":"Taiwan tuberculosis control report 2013","year":"2014"},{"key":"10.1016\/j.jmii.2017.05.008_bib22","first-page":"287","article-title":"Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings","volume":"15","author":"Lawn","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmii.2015.04.003","article-title":"Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"49","author":"Bakula","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.05.008_bib24","series-title":"Performance Standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jmii.2017.05.008_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jmii.2014.01.003","article-title":"Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples","volume":"49","author":"Yu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.05.008_bib26","first-page":"282","article-title":"Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance","volume":"14","author":"Kam","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1179\/joc.2008.20.2.202","article-title":"Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan","volume":"20","author":"Lu","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2017.05.008_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1086\/519939","article-title":"Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances","volume":"45","author":"Restrepo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","article-title":"Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State","volume":"15","author":"Mulu","year":"2015","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jmii.2017.05.008_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059414","article-title":"The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks","volume":"8","author":"Sirgel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2017.05.008_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.rmed.2012.10.021","article-title":"The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis","volume":"107","author":"Jo","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jmii.2017.05.008_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2016.01.019","article-title":"Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex","volume":"85","author":"Berrada","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.008_bib33","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/jac\/dkt150","article-title":"Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?","volume":"68","author":"Schon","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.05.008_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1179\/joc.1996.8.2.137","article-title":"Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in Taiwan","volume":"8","author":"Lee","year":"1996","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2017.05.008_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217301123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217301123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:22:14Z","timestamp":1761657734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217301123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1684118217301123"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2017.05.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}